Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Recurrent Head and Neck Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Early research (Phase 1)UnknownNCT00682227
What this trial is testing

Peptide Vaccination in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Yamanashi 10
Large-scale testing (Phase 3)Ended earlyNCT00004227
What this trial is testing

Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx

Who this might be right for
Head and Neck Cancer
University of Alabama at Birmingham 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05835804
What this trial is testing

Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckPaclitaxelCarboplatin+1 more
Centre Hospitalier Universitaire, Amiens 39
Large-scale testing (Phase 3)Study completedNCT03748134
What this trial is testing

Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )

Who this might be right for
Esophageal Squamous Cell Carcinoma
Innovent Biologics (Suzhou) Co. Ltd. 746
Large-scale testing (Phase 3)Ended earlyNCT00198315
What this trial is testing

Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Inovio Pharmaceuticals 130
Testing effectiveness (Phase 2)Ended earlyNCT04034225
What this trial is testing

Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Sensei Biotherapeutics, Inc. 25
Testing effectiveness (Phase 2)WithdrawnNCT05743270
What this trial is testing

Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLocally Advanced Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Replimune, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00101075
What this trial is testing

Title XELOX FOR SALIVARY GLAND CANCERS

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 9